Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy
Condition(s):Pancreas Cancer; DVT; Pulmonary EmbolismLast Updated:December 23, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Pancreas Cancer; DVT; Pulmonary EmbolismLast Updated:December 23, 2021Completed
Condition(s):Cancer-associated ThrombosisLast Updated:September 13, 2023Active, not recruiting
Condition(s):Short Bowel Syndrome; AnticoagulationLast Updated:February 23, 2024Recruiting
Condition(s):Venous Thromboembolism; AnticoagulantsLast Updated:February 24, 2023Terminated
Condition(s):Atrial FibrillationLast Updated:March 17, 2020Completed
Condition(s):Nephrotic Syndrome; ProteinuriaLast Updated:July 24, 2019Completed
Condition(s):Deep Vein ThrombosisLast Updated:July 29, 2021Not yet recruiting
Condition(s):Deep Venous Thrombosis; Upper Extremity Deep Venous Thrombosis; Thrombus; Venous Thromboembolism; Deep Vein ThrombosisLast Updated:September 28, 2023Terminated
Condition(s):Anti-Xa ActivityLast Updated:August 23, 2021Terminated
Condition(s):Venous ThromboembolismLast Updated:October 25, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.